VJHemOnc is committed to improving our service to you

COSTEM 2019 | HHV-6 infection management post-HSCT

VJHemOnc is committed to improving our service to you

Per Ljungman

Per Ljungman, MD, PhD, Karolinska University Hospital, Solna, Sweden, discusses the management of HHV-6 infection in patients with hematological malignancies after hematopoietic stem cell transplantation (HSCT). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter